"Tuesday's announcement from Merck that is acquiring Inspire Pharmaceuticals is interesting on a couple of fronts," so goes the post on SeekingAlpha.com. "It's interesting for the multiple that Merck is paying and it is a good exit for Inspire shareholders. It is also interesting because it leaves so few publicly traded stocks in the eye care sector."
Wednesday, April 6, 2011
The Small World of Eye Care Investors
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment